All the information you need about CELLONIS BIOTECHNOLOGIES FRANCE to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2021-10-20 | Public | 2020-12-31 | Complete |
| 2021-02-18 | Public | 2019-12-31 | Complete |
| Name | CELLONIS BIOTECHNOLOGIES FRANCE |
| Siren | 811400696 |
| Closing | 2019-12-31 |
| Registry code | 7702 |
| Registration number | 2854 |
| Management number | 2015B00809 |
| Activity code | 7211Z |
| Closing date n-1 | 2018-12-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 12 |
| Filing date | 2021-02-18 |
| Modification | 01 Annual accounts entered with accounting inconsistencies at document source |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Public |
| Address | 77370 Fontenailles |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
BZ Other receivables | 318 027.00 | 318 027.00 | 318 027.00 | |
CF Cash and cash equivalents | ||||
CJ TOTAL (II) | 318 027.00 | 318 027.00 | 318 027.00 | |
CO Grand total (0 to V) | 318 027.00 | 318 027.00 | 318 027.00 | |
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 200 000.00 | 200 000.00 | 200 000.00 | |
DH Retained earnings | -565 674.00 | -248 299.00 | -565 674.00 | |
DI RESULTS FOR THE YEAR (Profit or Loss) | 184 041.00 | -317 375.00 | 184 041.00 | |
DL TOTAL (I) | -181 633.00 | -365 674.00 | -181 633.00 | |
DX Trade payables and related accounts | 249 659.00 | 435 720.00 | 249 659.00 | |
EA Other liabilities | 250 000.00 | 250 000.00 | 250 000.00 | |
EC TOTAL (IV) | 499 659.00 | 685 720.00 | 499 659.00 | |
EE Grand total (I to V) | 318 027.00 | 320 046.00 | 318 027.00 | |
EG Accrued income and payables due within one year | 499 659.00 | 685 720.00 | 499 659.00 | |
| 3 - Income statement | Amount France year N | Amount Export year N | Total year N | Total year N-1 |
FQ Other income | 185 000.00 | |||
FR Total operating income (I) | 185 000.00 | |||
FW Other purchases and external expenses | -541.00 | |||
FX Taxes, duties, and similar payments | ||||
GF Total Operating Expenses (II) | -541.00 | |||
GG - OPERATING RESULT (I - II) | 185 541.00 | |||
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) | 185 541.00 | |||
| 4 - Income statement (continued) | Amount year N | Amount year N-1 | ||
HE Exceptional expenses on management operations | 1 500.00 | 1 500.00 | ||
HF Exceptional expenses on capital transactions | 130 500.00 | |||
HH Total exceptional expenses (VIII) | 1 500.00 | 130 500.00 | 1 500.00 | |
HI - EXCEPTIONAL RESULT (VII - VIII) | -1 500.00 | -130 500.00 | -1 500.00 | |
HL TOTAL REVENUE (I + III + V + VII) | 185 000.00 | 185 000.00 | ||
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) | 959.00 | 317 375.00 | 959.00 | |
HN PROFIT OR LOSS (Total revenue - Total expenses) | 184 041.00 | -317 375.00 | 184 041.00 | |
